Clinical Trial Update: Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing Ledipasvir/Sofosbuvir in genotype 1 hepatitis C virus infection patients receiving opiate substitution therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)

Snippet

Sponsor: Wilhelminenspital Vienna | Conditions: Chronic Hepatitis C | Phase 4 | Status: UNKNOWN